Gynecologic Cancer News

Whole-exome sequencing identified carriers of predisposition genes for hereditary breast and ovarian cancer or Lynch syndrome who, under current guidelines, would not have qualified for genetic testing, according to study results.

A deep learning model accurately identified women with endometrial cancer at low and high risk for distant recurrence, according to research presented at American Association for Cancer Research Annual Meeting.

Results of a survey study showed a decrease in the proportion of Americans who are aware that HPV causes cervical cancer, according to a presenter at American Association for Cancer Research Annual Meeting.

In a phase 1 trial of mistletoe extract for patients with cancer, researchers at Johns Hopkins Kimmel Cancer Center found the therapy to not only be safe but also potentially beneficial to quality of life.

University of Chicago Medicine Comprehensive Cancer Center has joined the National Comprehensive Cancer Network as its 33rd member institution.

HHS on Monday released the National Cancer Plan, which includes eight goals and strategies to prevent cancer, reduce related mortality and improve the lives of people living with the disease.

A quality improvement model successfully identified, educated and treated newly diagnosed women with gynecologic cancer at high risk for venous thromboembolism, according to study results.

The Healio Editors compiled a list of recent news from the Society of Gynecologic Oncology Annual Meeting held from March 25-28, 2023.

FDA granted full approval to pembrolizumab for treatment of certain adults and children with unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors as determined through an FDA-approved test.

A cloud-based chatbot considerably improved identification of high-risk pathogenic variants in cancer genes, according to study results.